UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Linde
LIN
|
+$776M |
| 3 |
Energy Transfer Partners
ET
|
+$580M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$479M |
| 5 |
UBS Group
UBS
|
+$380M |
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.06B |
| 2 |
Colgate-Palmolive
CL
|
+$633M |
| 3 |
PX
Praxair Inc
PX
|
+$528M |
| 4 |
Microsoft
MSFT
|
+$443M |
| 5 |
Amazon
AMZN
|
+$423M |
Sector Composition
| 1 | Technology | 10.17% |
| 2 | Financials | 8.41% |
| 3 | Healthcare | 7.93% |
| 4 | Consumer Discretionary | 6.47% |
| 5 | Industrials | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Jazz Pharmaceuticals
JAZZ
$7.7B
| $48.3M | 0.02% |
389,368
-56,114
| -13% | -$6.96M |
|
|
QEP
477
DELISTED
QEP RESOURCES, INC.
QEP
| $48.1M | 0.02% |
8,540,102
+2,878,706
| +51% | +$16.2M |
|
478
Invesco Senior Loan ETF
BKLN
$6.87B
| $47.8M | 0.02% |
2,194,326
-407,561
| -16% | -$8.88M |
|
|
HEP
479
DELISTED
Holly Energy Partners, L.P.
HEP
| $47.8M | 0.02% |
1,673,185
-130,310
| -7% | -$3.72M |
|
480
Unilever
UL
$154B
| $47.7M | 0.02% |
913,754
-637
| -0.1% | -$33.3K |
|
481
Kimberly-Clark
KMB
$42.5B
| $47.7M | 0.02% |
418,839
-45,145
| -10% | -$5.14M |
|
482
Schwab US Large- Cap ETF
SCHX
$59.8B
| $47.6M | 0.02% |
4,782,816
+1,455,462
| +44% | +$14.5M |
|
483
Calamos Strategic Total Return Fund
CSQ
$3.03B
| $47.4M | 0.02% |
4,475,481
+91,666
| +2% | +$971K |
|
484
Sysco
SYY
$38.3B
| $47.4M | 0.02% |
755,816
-163,768
| -18% | -$10.3M |
|
485
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.84B
| $47.2M | 0.02% |
498,467
+81,332
| +19% | +$7.7M |
|
486
First Trust Health Care AlphaDEX Fund
FXH
$914M
| $47.1M | 0.02% |
683,414
+245,093
| +56% | +$16.9M |
|
487
Akamai
AKAM
$11B
| $47M | 0.02% |
769,228
-99,027
| -11% | -$6.05M |
|
488
Fiserv
FI
$71.8B
| $46.9M | 0.02% |
638,750
-247,749
| -28% | -$18.2M |
|
489
First Trust Technology AlphaDEX Fund
FXL
$1.41B
| $46.7M | 0.02% |
888,662
-92,145
| -9% | -$4.84M |
|
490
Vanguard Industrials ETF
VIS
$6.11B
| $46.4M | 0.02% |
385,551
+40,815
| +12% | +$4.91M |
|
491
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.25B
| $46.4M | 0.02% |
809,310
+132,195
| +20% | +$7.58M |
|
|
EVV
492
Eaton Vance Limited Duration Income Fund
EVV
$1.2B
| $46.3M | 0.02% |
3,883,269
-248,815
| -6% | -$2.97M |
|
493
S&P Global
SPGI
$165B
| $46.1M | 0.02% |
271,518
-93,027
| -26% | -$15.8M |
|
494
Northrop Grumman
NOC
$83B
| $45.9M | 0.02% |
187,407
-23,413
| -11% | -$5.73M |
|
495
Invesco S&P MidCap Low Volatility ETF
XMLV
$811M
| $45.4M | 0.02% |
1,023,465
+567,614
| +125% | +$25.2M |
|
496
Vertex Pharmaceuticals
VRTX
$99.6B
| $45.4M | 0.02% |
274,070
-98,400
| -26% | -$16.3M |
|
497
Simon Property Group
SPG
$58.5B
| $45.2M | 0.02% |
269,202
-94,286
| -26% | -$15.8M |
|
498
Intuit
INTU
$183B
| $45.2M | 0.02% |
229,613
-168,148
| -42% | -$33.1M |
|
499
ProQR Therapeutics
PRQR
$237M
| $45M | 0.02% |
2,854,433
+2,854,207
| +1,262,923% | +$45M |
|
500
Genesis Energy
GEL
$2.03B
| $45M | 0.02% |
2,434,493
+324,164
| +15% | +$5.99M |
|